SVB Report Finds 2024 Resurgence In Healthtech Investment, Driven Largely By Investments In AI

Venture capital investment in healthtech is showing signs of early recovery in the first half of 2024 after the long hangover of a downturn that followed booming investments during the pandemic years, according to a new report from Silicon Valley Bank (SVB). Despite ongoing challenges, healthtech is on a positive trajectory and hovers between $3.5bn and $4.5bn per quarter, surpassing pre-pandemic levels.

Healthtech, AI (Shutterstock)

More from Financing

More from AI